Investigating the predictive ability of FLI for non-alcoholic fatty liver disease involvement
Student Research in Translational Medicine,
Vol. 4 (2022),
28 November 2022
https://doi.org/10.22037/smsj.v4i1.39588
Abstract
Background and aim: non-alcoholic fatty liver disease (NAFLD) is one of the common concerns in the world. This disease has a correlation with obesity, type 2 diabetes, metabolic syndrome, and other diseases. So, prediction and diagnosis of NAFLD is important. Fatty liver index can be used as a good method for prediction of NAFLD involvement but there are few evidences about it. The aim of this study was to investigate the prediction and diagnostic power of FLI to predict and diagnosis of NAFLD.
Materials and Methods: in this diagnostic study, patients who were referred to our hospital from 2020 to 2021 were assessed. Patients with NAFLD (N=108) were compared with normal people (N=220) based on age, sex, anthropometric parameters, laboratory data, and FLI.
Result: the mean age among all participants was 45.62 ± 10.93 years. There were significant differences between NAFLD group and normal group about age, sex, height, weight, BMI, waist circumference, diabetes and hypertension history, TG, LDL, AST, ALT, ALK,GGT. The sensitivity, specificity, and accuracy of FLI in diagnosis of NAFLD were 73.15%, 81.36%, and 78.66%, respectively. The best cut-off point based on ROC analysis and Youden index for differentiation of grade 1 from grade 2 was 69.5 and the best cut-off point for differentiation of grade 2 from grade 3 was 72.5 when the high FLI level considered as 60.
Conclusion: FLI is good method for prediction and diagnosis of NAFLD.
- Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Fatty liver index
How to Cite
References
2. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124-31.
3. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature reviews Gastroenterology & hepatology. 2018;15(1):11-20.
4. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.
5. Kang SY, Kim Y-J, Park HS. Trends in the prevalence of non-alcoholic fatty liver disease and its future predictions in Korean men, 1998–2035. Journal of Clinical Medicine. 2020;9(8):2626.
6. Wong W-K, Chan W-K. Nonalcoholic fatty liver disease: a global perspective. Clinical therapeutics. 2021;43(3):473-99.
7. Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Translational gastroenterology and hepatology. 2020;5.
8. Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389-97. e10.
9. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.
10. Loomba R, Wolfson T, Ang B, Hooker J, Behling C, Peterson M, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology. 2014;60(6):1920-8.
11. Albhaisi S, Issa D, Alkhouri N. Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden. Hepatobiliary Surgery and Nutrition. 2018;7(5):389.
12. Sookoian S, Pirola CJ. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Alimentary pharmacology & therapeutics. 2017;46(2):85-95.
13. Festi D, Schiumerini R, Marzi L, Di Biase A, Mandolesi D, Montrone L, et al. the diagnosis of non‐alcoholic fatty liver disease–availability and accuracy of non‐invasive methods. Alimentary pharmacology & therapeutics. 2013;37(4):392-400.
14. Otgonsuren M, Estep MJ, Hossain N, Younossi E, Frost S, Henry L, et al. A single non‐invasive model to diagnose non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH). Journal of gastroenterology and hepatology. 2014;29(12):2006-13.
15. Han AL. Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease. Diabetology & Metabolic Syndrome. 2022;14(1):1-7.
16. Meffert PJ, Baumeister SE, Lerch MM, Mayerle J, Kratzer W, Voelzke H. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis. Official journal of the American College of Gastroenterology| ACG. 2014;109(9):1404-14.
17. Jung C, Lee W, Hwang J, Yu J, Shin M, Lee M, et al. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. Diabetic medicine. 2013;30(4):428-35.
18. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC gastroenterology. 2006;6(1):1-7.
19. Castellana M, Donghia R, Guerra V, Procino F, Lampignano L, Castellana F, et al. Performance of fatty liver index in identifying non-alcoholic fatty liver disease in population studies. A meta-analysis. Journal of clinical medicine. 2021;10(9):1877.
20. Murayama K, Okada M, Tanaka K, Inadomi C, Yoshioka W, Kubotsu Y, et al. Prediction of nonalcoholic fatty liver disease using noninvasive and non-imaging procedures in Japanese health checkup examinees. Diagnostics. 2021;11(1):132.
21. Motamed N, Faraji AH, Khonsari MR, Maadi M, Tameshkel FS, Keyvani H, et al. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran. Clinical Nutrition. 2020;39(2):468-74.
22. Khang AR, Lee HW, Yi D, Kang YH, Son SM. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010–2011. Diabetes, metabolic syndrome and obesity: targets and therapy. 2019;12:181.
23. Hsu C-L, Wu F-Z, Lin K-H, Chen Y-H, Wu P-C, Chen Y-H, et al. Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup. Clinical and translational gastroenterology. 2019;10(5).
24. Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine. 2015;94(40).
- Abstract Viewed: 131 times
- PDF Downloaded: 19 times
